Dollar on the defensive as banking fears ebb; yen drops
Patrick Mahomes and Darius Slay lead backlash against NFL allowing teams to...
Mitsubishi Electric Develops Tomographic Imaging Technology to Visualize...
Win Streak May End For Thai Stock Market
London Taxis: 'It's cheaper to use petrol than electricity'
Patrick Mahomes and Darius Slay lead backlash against NFL allowing teams to...
Mitsubishi Electric Develops Tomographic Imaging Technology to Visualize...
Win Streak May End For Thai Stock Market
London Taxis: 'It's cheaper to use petrol than electricity'
Nemours
SciencePress Release2023-03-28 20:01:00
Company has initiated pre-IND discussions with the FDA for its first AIM INJ indication NEXI-001 completed enrollment in its final safety cohorts and all...
HealthPress Release2023-03-28 17:15:00
The new effort will rapidly accelerate the pace of cancer innovation, building on the White House Cancer Moonshot BOSTON, March 28, 2023 /PRNewswire/ --...
Business / FinanceBy Business Wire2023-03-28 10:45:00
The long-term program is focused on significantly lowering the carbon footprint of Chemours' glycolic acid grades by up to 80% against a 2023 baseline The...
SciencePress Release2023-03-28 15:00:00
Martinsried /M unich, March 28, 202 3. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an early-stage immuno-oncology platform company focusing on the...
HealthPress Release2023-03-29 07:08:00
STOCKHOLM, March 29, 2023 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin...
HealthPress Release2023-03-28 11:00:00
First-in-Class ERAP1 Inhibitor Enters Clinical Development Study to Evaluate GRWD5769 as Monotherapy, as well as in Combination with PD-1 Inhibitor Libtayo ®...
HealthPress Release2023-03-28 11:00:00
CAMBRIDGE, Mass., March 28, 2023 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) ("Theseus"), a clinical-stage biopharmaceutical company focused...
SciencePress Release2023-03-28 20:02:00
Figure 1: Swimmer Plot for Patients in the 200 mg Dose Cohort of the CPI-818 Phase 1/1b Clinical Trial for T Cell Lymphoma. The plot shows the tumor response...
SciencePress Release2023-03-28 11:30:00
PDS Biotech Provides Business Update and Reports Fourth-Quarter and Full-Year 2022 Financial Results
Successful meeting with FDA to discuss registrational pathway for triple combination of PDS0101, PDS0301, and a commercial immune checkpoint inhibitor 100%...
HealthPress Release2023-03-28 12:00:00
OMAHA, Neb. and BELGRADE, Maine, March 28, 2023 /PRNewswire/ -- Bot Image, Inc., a Nebraska and Maine based Artificial Intelligence medical device company,...
SciencePress Release2023-03-28 13:39:00
SAN DIEGO, March 28, 2023 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients...
SciencePress Release2023-03-28 20:01:00
SAN DIEGO and TORONTO, March 28, 2023 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage precision oncology company...
SciencePress Release2023-03-28 11:30:00
Sonoma Biotherapeutics to receive $75 million upfront, inclusive of $45 million cash and $30 million equity investment; potential for an additional $45...
Business / FinanceBy Business Wire2023-03-29 07:01:00
Through AI/ML-enabled platform with a biology-first approach, Genialis looks to propel drug development, diagnostics and treatment planning Genialis, a...
AutoPress Release2023-03-28 15:36:04
Our Mesothelioma Options Help Centers have a network of top doctors/surgeons from coast to coast. The Steinberg Law Group has decades of proven experience...
HealthBy Nina Massey2023-03-29 04:21:07
Scientists have found out how some skin cancers stop responding to treatment at the end of life. The findings allow researchers to see how melanoma evolves...
HealthPress Release2023-03-29 06:13:00
OSLO, Norway, March 29, 2023 /PRNewswire/ -- Navamedic ASA (OSE: NAVA), a Nordic pharma company and provider of high-quality products to hospitals and...
SciencePress Release2023-03-27 12:05:00
Experienced Leader Brings Extensive Clinical Development and Medical Affairs Expertise in Oncology FOSTER CITY, Calif., March 27, 2023 (GLOBE NEWSWIRE) --...
SciencePress Release2023-03-28 12:30:00
WORCESTER, Mass., March 28, 2023 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (Mustang or the Company) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company...
SciencePress Release2023-03-28 20:05:00
First cohort dosed in Phase 1 first-in-human dose-escalation study of VIP236, an v 3 small molecule drug conjugate (SMDC) in advanced solid tumors IND filing...